{"SPECIMEN TYPE": "SPECIMEN TYPE Block", "SPECIMEN SITE": "SPECIMEN SITE Lymph Node", "REPORT DATE": "19 Jan 2021", "Biomarker Findings": ["Microsatellite status - MS-Stable", "Tumor Mutational Burden - 3 Muts/Mb", ""], "Genomic Findings": ["For a complete list of the genes assayed, please refer to the Appendix.", "ERBB2 amplification", "CDK12 rearrangement exon 4", "RICTOR amplification", "CDKN2A/B p16INK4a G89V", "FAM123B G605D", "TP53 loss exons 10-11", ""], "ERBB2 - amplification": [["Ado-trastuzumab", "emtansine", "Trastuzumab", "Trastuzumab +", "Pertuzumab", "Trastuzumab +", "Tucatinib", "Fam-trastuzumab", "deruxtecan", "Lapatinib", "Lapatinib +", "Letrozole", "Neratinib", "Margetuximab"], ["Afatinib", "Dacomitinib"]], "CDK12 - rearrangement exon 4": [["none"], ["none"]], "RICTOR - amplification": [["none"], ["none", "NCCN category"]]}